SEARCH

SEARCH BY CITATION

References

  • Harris, M.B., Shuster, J.J., Carroll, A., Look, A.T., Borowitz, M.J., Crist, W.M., Nitschke, R., Pullen, J., Steuber, C.P. & Land, V.J. (1992) Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood, 79, 33163324.
  • Hasegawa, D., Manabe, A., Ohara, A., Kikuchi, A., Koh, K., Kiyokawa, N., Fukushima, T., Ishida, Y., Saito, T., Hanada, R. & Tsuchida, M. (2012) The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study. Pediatric Blood & Cancer, 58, 2330.
  • Heerema, N.A., Sather, H.N., Sensel, M.G., Zhang, T., Hutchinson, R.J., Nachman, J.B., Lange, B.J., Steinherz, P.G., Bostrom, B.C., Reaman, G.H., Gaynon, P.S. & Uckun, F.M. (2000) Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes). Journal of Clinical Oncology, 18, 18761887.
  • Igarashi, S., Manabe, A., Ohara, A., Kumagai, M., Saito, T., Okimoto, Y., Kamijo, T., Isoyama, K., Kajiwara, M., Sotomatsu, M., Sugita, K., Sugita, K., Maeda, M., Yabe, H., Kinoshita, A., Kaneko, T., Hayashi, Y., Ikuta, K., Hanada, R. & Tsuchida, M. (2005) No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol. Journal of Clinical Oncology, 23, 64896498.
  • Kato, M., Koh, K., Manabe, A., Saito, T., Hasegawa, D., Isoyama, K., Kinoshita, A., Maeda, M., Okimoto, Y., Kajiwara, M., Kaneko, T., Sugita, K., Kikuchi, A., Tsuchida, M. & Ohara, A. (2014) No impact of enhanced early intensification with intermediate-risk pediatric acute lymphoblastic leukemia: Results of Randomized Trial TCCSG study L99-15. British Journal of Haematology, 164, 376383.
  • Kawamata, N., Ogawa, S., Zimmermann, M., Kato, M., Sanada, M., Hemminki, K., Yamatomo, G., Nannya, Y., Koehler, R., Flohr, T., Miller, C.W., Harbott, J., Ludwig, W.D., Stanulla, M., Schrappe, M., Bartram, C.R. & Koeffler, H.P. (2008) Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood, 111, 776784.
  • Look, A.T., Roberson, P.K., Williams, D.L., Rivera, G., Bowman, W.P., Pui, C.H., Ochs, J., Abromowitch, M., Kalwinsky, D. & Dahl, G.V. (1985) Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood, 65, 10791086.
  • Manabe, A., Ohara, A., Hasegawa, D., Koh, K., Saito, T., Kiyokawa, N., Kikuchi, A., Takahashi, H., Ikuta, K., Hayashi, Y., Hanada, R. & Tsuchida, M. (2008) Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15. Haematologica, 93, 11551160.
  • Sutcliffe, M.J., Shuster, J.J., Sather, H.N., Camitta, B.M., Pullen, J., Schultz, K.R., Borowitz, M.J., Gaynon, P.S., Carroll, A.J. & Heerema, N.A. (2005) High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative. Leukemia, 19, 734740.
  • Suzuki, N., Yumura-Yagi, K., Yoshida, M., Hara, J., Nishimura, S., Kudoh, T., Tawa, A., Usami, I., Tanizawa, A., Hori, H., Ito, Y., Miyaji, R., Oda, M., Kato, K., Hamamoto, K., Osugi, Y., Hashii, Y., Nakahata, T. & Horibe, K. & Japan Association of Childhood Leukemia Study (2010) Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol. Pediatric Blood & Cancer, 54, 7178.